The University of Chicago Header Logo

Connection

Larry Goldstein to Middle Aged

Back to Details
This is a "connection" page, showing publications Larry Goldstein has written about Middle Aged.
Larry Goldstein
Connection Strength
1.268
Middle Aged
  1. Vascular Cellular Adhesion Molecule-1 (VCAM-1) and Memory Impairment in African-Americans after Small Vessel-Type Stroke. J Stroke Cerebrovasc Dis. 2020 Apr; 29(4):104646.
    View in: PubMed
    Score: 0.046
  2. Effect of Known Atrial Fibrillation and Anticoagulation Status on the Prehospital Identification of Large Vessel Occlusion. J Stroke Cerebrovasc Dis. 2019 Dec; 28(12):104404.
    View in: PubMed
    Score: 0.044
  3. Effect of Dextroamphetamine on Poststroke Motor Recovery: A Randomized Clinical Trial. JAMA Neurol. 2018 12 01; 75(12):1494-1501.
    View in: PubMed
    Score: 0.042
  4. Influence of Dietary Salt Knowledge, Perceptions, and Beliefs on Consumption Choices after Stroke in Uganda. J Stroke Cerebrovasc Dis. 2017 Dec; 26(12):2935-2942.
    View in: PubMed
    Score: 0.038
  5. BE-FAST (Balance, Eyes, Face, Arm, Speech, Time): Reducing the Proportion of Strokes Missed Using the FAST Mnemonic. Stroke. 2017 02; 48(2):479-481.
    View in: PubMed
    Score: 0.037
  6. Utility of Urgent Computed Tomography Angiography in the Setting of Intraparenchymal Brain Hemorrhage. J Stroke Cerebrovasc Dis. 2017 Feb; 26(2):417-419.
    View in: PubMed
    Score: 0.036
  7. Influence of sodium consumption and associated knowledge on poststroke hypertension in Uganda. Neurology. 2016 Sep 20; 87(12):1198-205.
    View in: PubMed
    Score: 0.036
  8. Average Temperature, Diurnal Temperature Variation, and Stroke Hospitalizations. J Stroke Cerebrovasc Dis. 2016 Jun; 25(6):1489-94.
    View in: PubMed
    Score: 0.035
  9. Routine 24-Hour Computed Tomography Brain Scan is not useful in stable patients Post Intravenous Tissue Plasminogen Activator. J Stroke Cerebrovasc Dis. 2016 Mar; 25(3):540-2.
    View in: PubMed
    Score: 0.034
  10. JURaSSiC: accuracy of clinician vs risk score prediction of ischemic stroke outcomes. Neurology. 2013 Jul 30; 81(5):448-55.
    View in: PubMed
    Score: 0.029
  11. Poststroke hypertension in Africa. Stroke. 2012 Dec; 43(12):3402-4.
    View in: PubMed
    Score: 0.027
  12. "Code stroke": hospitalized versus emergency department patients. J Stroke Cerebrovasc Dis. 2013 May; 22(4):345-8.
    View in: PubMed
    Score: 0.026
  13. Concerns for the reliability and validity of the National Stroke Project Stroke Severity Scale. Cerebrovasc Dis. 2011; 32(5):426-30.
    View in: PubMed
    Score: 0.026
  14. Echocardiography for the detection of cardiac sources of embolism in patients with stroke or transient ischemic attack. J Stroke Cerebrovasc Dis. 2012 Oct; 21(7):577-82.
    View in: PubMed
    Score: 0.025
  15. Exploration of a hypothesized independent association of a common 9p21.3 gene variant and ischemic stroke in patients with and without angiographic coronary artery disease. Cerebrovasc Dis. 2011; 31(2):117-22.
    View in: PubMed
    Score: 0.024
  16. Hospital arrival time and intravenous t-PA use in US Academic Medical Centers, 2001-2004. Stroke. 2009 Dec; 40(12):3845-50.
    View in: PubMed
    Score: 0.022
  17. Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2009 Nov; 40(11):3526-31.
    View in: PubMed
    Score: 0.022
  18. Stroke-related knowledge among uninsured Latino immigrants in Durham County, North Carolina. J Stroke Cerebrovasc Dis. 2009 May-Jun; 18(3):229-31.
    View in: PubMed
    Score: 0.022
  19. Lack of impact of paramedic training and use of the cincinnati prehospital stroke scale on stroke patient identification and on-scene time. Stroke. 2009 Mar; 40(3):754-6.
    View in: PubMed
    Score: 0.021
  20. How much can be gained by more systematic prevention of stroke? Int J Stroke. 2008 Nov; 3(4):266-71.
    View in: PubMed
    Score: 0.021
  21. Relative effects of statin therapy on stroke and cardiovascular events in men and women: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study. Stroke. 2008 Sep; 39(9):2444-8.
    View in: PubMed
    Score: 0.020
  22. Impact of comorbidities on ischemic stroke outcomes in women. Stroke. 2008 Jul; 39(7):2138-40.
    View in: PubMed
    Score: 0.020
  23. Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology. 2008 Jun 10; 70(24 Pt 2):2364-70.
    View in: PubMed
    Score: 0.020
  24. Stroke code chest radiographs are not useful. Cerebrovasc Dis. 2007; 24(5):460-2.
    View in: PubMed
    Score: 0.019
  25. Advances in primary stroke prevention. Stroke. 2006 Feb; 37(2):317-9.
    View in: PubMed
    Score: 0.017
  26. Charlson Index comorbidity adjustment for ischemic stroke outcome studies. Stroke. 2004 Aug; 35(8):1941-5.
    View in: PubMed
    Score: 0.015
  27. Association of Antithrombotic Drug Use With Incident Intracerebral Hemorrhage Location. Neurology. 2024 Jun 25; 102(12):e209442.
    View in: PubMed
    Score: 0.015
  28. Editorial comment--Prenatal influences on stroke mortality in England and Wales. Stroke. 2003 Jul; 34(7):1602-3.
    View in: PubMed
    Score: 0.014
  29. Contrast-enhanced magnetic resonance angiography of carotid arteries: utility in routine clinical practice. Stroke. 2002 Dec; 33(12):2834-8.
    View in: PubMed
    Score: 0.014
  30. Homocysteine testing in patients with acute ischemic stroke. Neurology. 2002 Nov 26; 59(10):1541-6.
    View in: PubMed
    Score: 0.014
  31. Low rate of complications of cerebral angiography in routine clinical practice. Neurology. 2001 Dec 11; 57(11):2012-4.
    View in: PubMed
    Score: 0.013
  32. Improving patient selection for coagulopathy testing in the setting of acute ischemic stroke. Neurology. 2001 Oct 09; 57(7):1333-5.
    View in: PubMed
    Score: 0.013
  33. Delay between stroke onset and emergency department evaluation. Neuroepidemiology. 2001 Aug; 20(3):196-200.
    View in: PubMed
    Score: 0.013
  34. Hormone replacement therapy and ischemic stroke severity in women: a case-control study. Neurology. 2001 May 22; 56(10):1304-7.
    View in: PubMed
    Score: 0.012
  35. Clinical carotid endarterectomy decision making: noninvasive vascular imaging versus angiography. Neurology. 2001 Apr 24; 56(8):1009-15.
    View in: PubMed
    Score: 0.012
  36. Use of specialized coagulation testing in the evaluation of patients with acute ischemic stroke. Neurology. 2001 Mar 13; 56(5):624-7.
    View in: PubMed
    Score: 0.012
  37. Diagnostic testing for coagulopathies in patients with ischemic stroke. Stroke. 2000 Dec; 31(12):3067-78.
    View in: PubMed
    Score: 0.012
  38. Diabetic microcirculatory disturbances and pathologic erythropoiesis are provoked by deposition of amyloid-forming amylin in red blood cells and capillaries. Kidney Int. 2020 01; 97(1):143-155.
    View in: PubMed
    Score: 0.011
  39. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys. 1999 Jul 15; 44(5):1005-15.
    View in: PubMed
    Score: 0.011
  40. Postmenopausal hormone replacement therapy: effect on diagnosis and outcome in early-stage invasive breast cancer treated with conservative surgery and radiation. J Clin Oncol. 1999 Jun; 17(6):1680-8.
    View in: PubMed
    Score: 0.011
  41. Development of a Non-invasive Device for Swallow Screening in Patients at Risk of Oropharyngeal Dysphagia: Results from a Prospective Exploratory Study. Dysphagia. 2019 10; 34(5):698-707.
    View in: PubMed
    Score: 0.011
  42. Reliability and validity of the SA-45: further evidence from a primary care setting. Assessment. 1998 Dec; 5(4):407-19.
    View in: PubMed
    Score: 0.010
  43. Randomized Sham-Controlled Trial of Navigated Repetitive Transcranial Magnetic Stimulation for Motor Recovery in Stroke. Stroke. 2018 09; 49(9):2138-2146.
    View in: PubMed
    Score: 0.010
  44. Association of Osteopontin, Neopterin, and Myeloperoxidase With Stroke Risk in Patients With Prior Stroke or Transient Ischemic Attacks: Results of an Analysis of 13 Biomarkers From the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trial. Stroke. 2017 12; 48(12):3223-3231.
    View in: PubMed
    Score: 0.010
  45. Statins and the Risk of Intracerebral Hemorrhage in Patients With Previous Ischemic Stroke or Transient Ischemic Attack. Stroke. 2017 12; 48(12):3245-3251.
    View in: PubMed
    Score: 0.010
  46. Clinical Reasoning: Two see or not two see-Is it really double vision? Neurology. 2017 08 08; 89(6):e56-e60.
    View in: PubMed
    Score: 0.010
  47. Prevalence of hyperactive digastric muscles during swallowing as measured by electromyography in patients with myofascial pain dysfunction syndrome. Funct Orthod. 1997 May-Jul; 14(3):18-22, 24.
    View in: PubMed
    Score: 0.009
  48. Depression Status Is Associated with Functional Decline Over 1-Year Following Acute Stroke. J Stroke Cerebrovasc Dis. 2017 Jul; 26(7):1393-1399.
    View in: PubMed
    Score: 0.009
  49. Ischemic Stroke with Troponin Elevation: Patient Characteristics, Resource Utilization, and In-Hospital Outcomes. Cerebrovasc Dis. 2016; 42(3-4):213-23.
    View in: PubMed
    Score: 0.009
  50. Comparison and meta-analysis of randomized trials of endarterectomy for symptomatic carotid artery stenosis. Neurology. 1995 Nov; 45(11):1965-70.
    View in: PubMed
    Score: 0.008
  51. Chronic Systemic Immune Dysfunction in African-Americans with Small Vessel-Type Ischemic Stroke. Transl Stroke Res. 2015 Dec; 6(6):430-6.
    View in: PubMed
    Score: 0.008
  52. US national survey of physician practices for the secondary and tertiary prevention of ischemic stroke. Design, service availability, and common practices. Stroke. 1995 Sep; 26(9):1607-15.
    View in: PubMed
    Score: 0.008
  53. Common drugs may influence motor recovery after stroke. The Sygen In Acute Stroke Study Investigators. Neurology. 1995 May; 45(5):865-71.
    View in: PubMed
    Score: 0.008
  54. A geographic information system analysis of the impact of a statewide acute stroke emergency medical services routing protocol on community hospital bypass. J Stroke Cerebrovasc Dis. 2014 Nov-Dec; 23(10):2800-2808.
    View in: PubMed
    Score: 0.008
  55. Real-time assessment of relapse risk based on the WT1 marker in acute leukemia and myelodysplastic syndrome patients after hematopoietic cell transplantation. Bone Marrow Transplant. 2015 Jan; 50(1):26-33.
    View in: PubMed
    Score: 0.008
  56. Effect of high-dose atorvastatin on renal function in subjects with stroke or transient ischemic attack in the SPARCL trial. Stroke. 2014 Oct; 45(10):2974-82.
    View in: PubMed
    Score: 0.008
  57. Neighborhood socioeconomic status and the prevalence of stroke and coronary heart disease in rural China: a population-based study. Int J Stroke. 2015 Apr; 10(3):388-95.
    View in: PubMed
    Score: 0.008
  58. Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients. Stroke. 2014 May; 45(5):1429-36.
    View in: PubMed
    Score: 0.008
  59. Prediction of major vascular events after stroke: the stroke prevention by aggressive reduction in cholesterol levels trial. J Stroke Cerebrovasc Dis. 2014 Apr; 23(4):778-84.
    View in: PubMed
    Score: 0.008
  60. Extended-release niacin therapy and risk of ischemic stroke in patients with cardiovascular disease: the Atherothrombosis Intervention in Metabolic Syndrome with low HDL/High Triglycerides: Impact on Global Health Outcome (AIM-HIGH) trial. Stroke. 2013 Oct; 44(10):2688-93.
    View in: PubMed
    Score: 0.007
  61. Death and rehospitalization after transient ischemic attack or acute ischemic stroke: one-year outcomes from the adherence evaluation of acute ischemic stroke-longitudinal registry. J Stroke Cerebrovasc Dis. 2013 Oct; 22(7):e181-8.
    View in: PubMed
    Score: 0.007
  62. Regional variation in recommended treatments for ischemic stroke and TIA: Get with the Guidelines--Stroke 2003-2010. Stroke. 2012 Jul; 43(7):1858-64.
    View in: PubMed
    Score: 0.007
  63. Depression and antidepressant use after stroke and transient ischemic attack. Stroke. 2012 Jun; 43(6):1609-16.
    View in: PubMed
    Score: 0.007
  64. Health-related quality of life after carotid stenting versus carotid endarterectomy: results from CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial). J Am Coll Cardiol. 2011 Oct 04; 58(15):1557-65.
    View in: PubMed
    Score: 0.006
  65. Secondary preventive medication persistence and adherence 1 year after stroke. Neurology. 2011 Sep 20; 77(12):1182-90.
    View in: PubMed
    Score: 0.006
  66. Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Arch Neurol. 2011 Oct; 68(10):1245-51.
    View in: PubMed
    Score: 0.006
  67. Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST). Stroke. 2011 Mar; 42(3):675-80.
    View in: PubMed
    Score: 0.006
  68. Posttransplantation hepatitis B prophylaxis with combination oral nucleoside and nucleotide analog therapy. Am J Transplant. 2011 Mar; 11(3):511-7.
    View in: PubMed
    Score: 0.006
  69. Similar secondary stroke prevention and medication persistence rates among rural and urban patients. J Rural Health. 2011; 27(4):401-8.
    View in: PubMed
    Score: 0.006
  70. A microcomputerized task assessment of cognitive change in normal elderly and young adults. Exp Aging Res. 1991; 17(2):119-21.
    View in: PubMed
    Score: 0.006
  71. Differential patterns of cognitive decline in anterior and posterior white matter hyperintensity progression. Stroke. 2010 Sep; 41(9):1946-50.
    View in: PubMed
    Score: 0.006
  72. Relative and cumulative effects of lipid and blood pressure control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels trial. Stroke. 2009 Jul; 40(7):2486-92.
    View in: PubMed
    Score: 0.005
  73. Diagnostic evaluation for patients with ischemic stroke: are there sex differences? Cerebrovasc Dis. 2009; 27(5):450-5.
    View in: PubMed
    Score: 0.005
  74. The Adherence eValuation After Ischemic Stroke Longitudinal (AVAIL) registry: design, rationale, and baseline patient characteristics. Am Heart J. 2009 Mar; 157(3):428-435.e2.
    View in: PubMed
    Score: 0.005
  75. Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes. Stroke. 2009 Apr; 40(4):1405-9.
    View in: PubMed
    Score: 0.005
  76. Utilization of intravenous tissue plasminogen activator for ischemic stroke: are there sex differences? Cerebrovasc Dis. 2009; 27(3):254-8.
    View in: PubMed
    Score: 0.005
  77. Physician prescribing patterns following hospital admission for ischemic cerebrovascular disease. Neurology. 1988 Nov; 38(11):1806-9.
    View in: PubMed
    Score: 0.005
  78. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2008 Dec; 39(12):3297-302.
    View in: PubMed
    Score: 0.005
  79. Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Atherosclerosis. 2009 Jun; 204(2):515-20.
    View in: PubMed
    Score: 0.005
  80. Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack. Neurology. 2009 Feb 24; 72(8):688-94.
    View in: PubMed
    Score: 0.005
  81. Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2007 Dec; 38(12):3198-204.
    View in: PubMed
    Score: 0.005
  82. Statin use and sex-specific stroke outcomes in patients with vascular disease. Stroke. 2006 Jun; 37(6):1427-31.
    View in: PubMed
    Score: 0.004
  83. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006 Feb; 37(2):577-617.
    View in: PubMed
    Score: 0.004
  84. Stroke location, characterization, severity, and outcome in mitral vs aortic valve endocarditis. Neurology. 2003 Nov 25; 61(10):1341-6.
    View in: PubMed
    Score: 0.004
  85. Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study. Cerebrovasc Dis. 2003; 16(4):389-95.
    View in: PubMed
    Score: 0.003
  86. Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial. JAMA. 2001 Dec 05; 286(21):2673-82.
    View in: PubMed
    Score: 0.003
  87. Gram-Negative anaerobic endocarditis: two case reports and review of the literature. Eur J Clin Microbiol Infect Dis. 2001 Sep; 20(9):651-4.
    View in: PubMed
    Score: 0.003
  88. Assessment of aspiration risk in stroke patients with quantification of voluntary cough. Neurology. 2001 Feb 27; 56(4):502-6.
    View in: PubMed
    Score: 0.003
  89. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy. Liver Transpl. 2000 Nov; 6(6):741-8.
    View in: PubMed
    Score: 0.003
  90. Improved outcome after intestinal transplantation: an 8-year, single-center experience. Transplant Proc. 2000 Sep; 32(6):1233-4.
    View in: PubMed
    Score: 0.003
  91. Quality of anticoagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities. Arch Intern Med. 2000 Apr 10; 160(7):967-73.
    View in: PubMed
    Score: 0.003
  92. Utilities for major stroke: results from a survey of preferences among persons at increased risk for stroke. Am Heart J. 1998 Oct; 136(4 Pt 1):703-13.
    View in: PubMed
    Score: 0.003
  93. A comprehensive assessment of the cost of multiple sclerosis in the United States. Mult Scler. 1998 Oct; 4(5):419-25.
    View in: PubMed
    Score: 0.003
  94. Diagnosis of intracranial vasculitis: a multi-disciplinary approach. J Neuropathol Exp Neurol. 1998 Jan; 57(1):30-8.
    View in: PubMed
    Score: 0.002
  95. Influence of projected complication rates on estimated appropriate use rates for carotid endarterectomy. Appropriateness Project Investigators. Academic Medical Center Consortium. Health Serv Res. 1997 Aug; 32(3):325-42.
    View in: PubMed
    Score: 0.002
  96. Knowledge of risk among patients at increased risk for stroke. Stroke. 1997 May; 28(5):916-21.
    View in: PubMed
    Score: 0.002
  97. Health status of individuals with mild stroke. Stroke. 1997 Apr; 28(4):740-5.
    View in: PubMed
    Score: 0.002
  98. Coccidioidomycosis in liver transplant patients. Clin Infect Dis. 1997 Feb; 24(2):216-21.
    View in: PubMed
    Score: 0.002
  99. The physiology of coloured hearing. A PET activation study of colour-word synaesthesia. Brain. 1995 Jun; 118 ( Pt 3):661-76.
    View in: PubMed
    Score: 0.002
  100. Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial. Stroke. 1995 Apr; 26(4):602-5.
    View in: PubMed
    Score: 0.002
  101. Predicting complications of carotid endarterectomy. Stroke. 1993 Sep; 24(9):1285-91.
    View in: PubMed
    Score: 0.002
  102. Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst. 1993 Jul 07; 85(13):1074-80.
    View in: PubMed
    Score: 0.002
  103. Measurement of motor recovery after stroke. Outcome assessment and sample size requirements. Stroke. 1992 Aug; 23(8):1084-9.
    View in: PubMed
    Score: 0.002
  104. Quantitative EEG analysis of single-dose effect relationships in normal volunteers of Pacinox (capuride), a new antianxiety drug. Biol Psychiatry. 1971; 3(2):165-72.
    View in: PubMed
    Score: 0.002
  105. Large-dose infusions of heparinoid ORG 10172 in ischemic stroke. Stroke. 1990 Sep; 21(9):1289-92.
    View in: PubMed
    Score: 0.001
  106. Dental pathology and alcohol-related indicators in an outpatient clinic sample. Community Dent Oral Epidemiol. 1990 Aug; 18(4):204-7.
    View in: PubMed
    Score: 0.001
  107. A comparative study of the effects of methaqualone and glutethimide on sleep in male chronic insomniacs. J Clin Pharmacol J New Drugs. 1970 Jul-Aug; 10(4):258-68.
    View in: PubMed
    Score: 0.001
  108. A dose escalation study of ORG 10172 (low molecular weight heparinoid) in stroke. Neurology. 1989 Feb; 39(2 Pt 1):262-5.
    View in: PubMed
    Score: 0.001
  109. Effects of parenteral administration of haloperidol and chlorpromazine in man. I. Normal subjects: quantitative EEG and subjective response. J Clin Pharmacol J New Drugs. 1968 Mar-Apr; 8(2):79-88.
    View in: PubMed
    Score: 0.000
  110. Effects of parenteral administration of haloperidol in man. II. Male chronic schizophrenics: quantitative EEG findings. J Clin Pharmacol J New Drugs. 1968 Mar-Apr; 8(2):89-94.
    View in: PubMed
    Score: 0.000
  111. Time-series analysis of the effects of barbiturates on the electroencephalograms of psychotic and nonpsychotic men. Clin Pharmacol Ther. 1967 Nov-Dec; 8(6):830-40.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.